Evan R. Roberts

455 total citations
19 papers, 276 citations indexed

About

Evan R. Roberts is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Evan R. Roberts has authored 19 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Evan R. Roberts's work include Melanoma and MAPK Pathways (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Evan R. Roberts is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Evan R. Roberts collaborates with scholars based in United States, Spain and Japan. Evan R. Roberts's co-authors include Daniel Bilbao, John M. Koomen, Bin Fang, Lixin Wan, Minjung Kim, Mengmeng Zheng, Tao Han, Keiran S.M. Smalley, Qing Yin and Guolin Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Evan R. Roberts

16 papers receiving 274 citations

Peers

Countries citing papers authored by Evan R. Roberts

Since Specialization

Citations

This map shows the geographic impact of Evan R. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan R. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan R. Roberts more than expected).

Fields of papers citing papers by Evan R. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan R. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan R. Roberts. The network helps show where Evan R. Roberts may publish in the future.

Co-authorship network of co-authors of Evan R. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Evan R. Roberts. A scholar is included among the top collaborators of Evan R. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan R. Roberts. Evan R. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Decoding the Pivotal Roles of BCL10 Activating Mutations in DLBCL Drug Resistance and Lymphomagenesis 2024 ·Blood ·Caroline A. Coughlin, (unknown), (unknown), (unknown), (unknown), Lingxiao Li, Evan R. Roberts, (unknown), (unknown), Ola Landgren, Shaun P. Brothers, Anthony J. Griswold, Catalina Amador, Daniel Bilbao, Francesco Maura, Jonathan H. Schatz	0
2	Targeting cancer stem cells by TPA leads to inhibition of refractory sarcoma and extended overall survival 2024 ·SHILAP Revista de lepidopterología ·Karina Galoian, Daniel Bilbao, Carina Denny, (unknown), Evan R. Roberts, (unknown), H. Thomas Temple	1
3	Altered RNA Export in SF3B1 Mutants Increases Sensitivity to Nuclear Export Inhibition 2023 ·Blood ·(unknown), Felipe Beckedorff, Tulasigeri M. Totiger, Maurizio Affer, (unknown), (unknown), (unknown), Daniel Bilbao, Evan R. Roberts, (unknown), José Antonio Rodríguez, Eric Wang, Justin Taylor	1
4	Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein 2023 ·Pharmaceutics ·(unknown), Yuping Yang, Evan R. Roberts, Daniel Bilbao, Wensi Tao, Alan Pollack, Sylvia Daunert, Sapna K. Deo	6
5	EPCO-27. RECONSTRUCTION OF THE SPATIAL ECOSYSTEM OF GLIOBLASTOMA REVEALS RECURRENT RELATIONSHIPS BETWEEN TUMOR CELL STATES AND TUMOR MICROENVIRONMENT 2023 ·Neuro-Oncology ·(unknown), Simona Migliozzi, Luciano Garofano, Young Taek Oh, Sakir H. Gultekin, Fulvio D’Angelo, Evan R. Roberts, Daniel Bilbao, (unknown), Siôn L. Williams, Benjamin Currall, Michele Ceccarelli, Anna Lasorella, Antonio Iavarone	0
6	Artificial Intelligence of the 2-D and 3-D Bone Marrow Microenvironment to Identify Cytogenetic Subtypes of Multiple Myeloma 2023 ·Blood ·(unknown), David G. Coffey, (unknown), (unknown), (unknown), Dan Qu, Daniel Bilbao, Evan R. Roberts, (unknown), (unknown), Francesco Maura, Jennifer R. Chapman‐Fredricks, Ola Landgren	0
7	Abstract 1771: Characterization of RHOA inactivation as a driver of CAR-T therapy resistance in diffuse large B-cell lymphoma 2023 ·Cancer Research ·(unknown), Yitzhar Goretsky, Evan R. Roberts, Daniel Bilbao, Jonathan H. Schatz	1
8	Aminopyridine analogs selectively target metastatic pancreatic cancer 2022 ·Oncogene ·Rana V. Smalling, Matthew E. Bechard, J. Duryea, Philip J. Kingsley, Evan R. Roberts, Lawrence J. Marnett, Daniel Bilbao, Shaun R. Stauffer, Oliver G. McDonald	2
9	Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargo 2022 ·eLife ·Sharon J. Elliot, Paola Catanuto, Simone Pereira‐Simon, Xiaomei Xia, Shahriar Shahzeidi, Evan R. Roberts, John W. Ludlow, (unknown), Sylvia Daunert, (unknown), R. Stone, Irena Pastar, Marjana Tomic‐Canic, Marilyn K. Glassberg	14
10	Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14) 2022 ·npj Precision Oncology ·(unknown), (unknown), Tulasigeri M. Totiger, (unknown), Evan R. Roberts, (unknown), (unknown), (unknown), (unknown), Maurizio Affer, (unknown), Terrence Bradley, Francesco Maura, Dickran Kazandjian, Daniel Bilbao, Jennifer R. Chapman, Ola Landgren, James E. Hoffman, Justin Taylor	12
11	Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors 2021 ·Cancer Research ·(unknown), Piumi Y. Liyanage, Asaad Trabolsi, Evan R. Roberts, Lingxiao Li, Braulio C.L.B. Ferreira, Zhen Gao, Yuguang Ban, (unknown), Melissa W. Taggart, Francisco Vega, Daniel Bilbao, Roger M. Leblanc, Jonathan H. Schatz	18
12	Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome 2021 ·Cell Reports ·J.J.David Ho, (unknown), (unknown), Caroline A. Coughlin, (unknown), Evan R. Roberts, (unknown), (unknown), Daniel Bilbao, Jonathan R. Krieger, Stephen Lee, Jonathan H. Schatz	17
13	Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma 2020 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), Daniel A. Rodriguez, (unknown), Stefan Kurtenbach, Daniel Bilbao, Evan R. Roberts, Claude‐Henry Volmar, Claes Wahlestedt, Shaun P. Brothers, J. William Harbour	25
14	Size-dependent intranasal administration of magnetoelectric nanoparticles for targeted brain localization 2020 ·Nanomedicine Nanotechnology Biology and Medicine ·Marta Pardo, Evan R. Roberts, (unknown), (unknown), (unknown), (unknown), Elric Zhang, Ping Liang, Sakhrat Khizroev	29
15	The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma 2019 ·Oncogene ·(unknown), Amit Dipak Amin, Lingxiao Li, Delphine Rolland, Haiquan Li, Deukwoo Kwon, (unknown), (unknown), Evan R. Roberts, Aimin Yan, Venkatesha Basrur, Kojo S.J. Elenitoba‐Johnson, Xi Chen, Soham D. Puvvada, Yves A. Lussier, Daniel Bilbao, Megan S. Lim, Jonathan H. Schatz	6
16	K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling 2019 ·Nature Communications ·Qing Yin, Tao Han, Bin Fang, Guolin Zhang, Chao Zhang, Evan R. Roberts, Victoria Izumi, Mengmeng Zheng, Shulong Jiang, (unknown), Minjung Kim, Jianfeng Cai, Eric B. Haura, John M. Koomen, Keiran S.M. Smalley, Lixin Wan	62
17	LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL 2019 ·Cancer Cell ·Salma Parvin, Ariel Ramírez-Labrada, Shlomzion Aumann, (unknown), (unknown), (unknown), Elena M. Cortizas, (unknown), (unknown), Isidro Sánchez‐García, Andrew J. Gentles, Evan R. Roberts, Daniel Bilbao, Francisco Vega, Jennifer R. Chapman, Ramiro E. Verdún, Izidore S. Lossos	48
18	PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas 2018 ·Molecular Cancer Research ·Kristen S. Hill, Evan R. Roberts, Xue Wang, (unknown), (unknown), (unknown), Yuan Ren, Bin Fang, Sean Yoder, Sungjune Kim, Lixin Wan, Amod A. Sarnaik, John M. Koomen, Jane L. Messina, Jamie K. Teer, Youngchul Kim, Jie Wu, Charles E. Chalfant, Minjung Kim	32
19	Abstract B12: The importance of the RASA1/R-Ras/Ral-A signaling axis in melanoma tumorigenesis 2018 ·Cancer Research ·Kristen S. Hill, Xue Wang, Evan R. Roberts, Youngchul Kim, Jane L. Messina, Minjung Kim	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact